Neuropharmacology

Neuropharmacology explores the interaction of drugs with the nervous system to treat neurological and psychiatric disorders. This track covers neurotransmitter systems, neurodegenerative diseases, pain management, epilepsy, and psychiatric therapeutics. Researchers will discuss emerging treatments for Alzheimer's disease, Parkinson's disease, and depression. Advances in neuroprotective agents and brain-targeted drug delivery will be highlighted. Innovative neuroscience research supporting therapeutic discoveries will also be presented. The track promotes better neurological healthcare outcomes.

    Related Conference of Neuropharmacology

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Neuropharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in